Inhibition of inflammation and senescence with azole compound C7 enables expansion of hematopoietic stem and progenitor cells
RNA-seq (gene expression) · human · 45 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 45 samples: 45 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE326276_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1445057 and SRA study SRP687686. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 45 sample titles: 45 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9626870 CB42389 treatment A
- GSM9626871 CB42389 treatment B
- GSM9626872 CB42389 treatment C
- GSM9626873 CB42389 treatment D
- GSM9626874 CB42389 uncultured
- GSM9626875 CB42557 treatment A
- GSM9626876 CB42557 treatment B
- GSM9626877 CB42557 treatment C
- GSM9626878 CB42557 treatment D
- GSM9626879 CB42557 uncultured
- GSM9626880 CB42988 treatment A
- GSM9626881 CB42988 treatment B
- GSM9626882 CB42988 treatment C
- GSM9626883 CB42988 treatment D
- GSM9626884 CB42988 uncultured
- GSM9626885 CB46894 treatment A
- GSM9626886 CB46894 treatment B
- GSM9626887 CB46894 treatment C
- GSM9626888 CB46894 treatment D
- GSM9626889 CB46894 uncultured
- GSM9626890 CB48726 treatment A
- GSM9626891 CB48726 treatment B
- GSM9626892 CB48726 treatment C
- GSM9626893 CB48726 treatment D
- GSM9626894 CB48726 uncultured
- GSM9626895 CB49636 treatment A
- GSM9626896 CB49636 treatment B
- GSM9626897 CB49636 treatment C
- GSM9626898 CB49636 treatment D
- GSM9626899 CB49636 uncultured
- GSM9626900 CB49847 treatment A
- GSM9626901 CB49847 treatment B
- GSM9626902 CB49847 treatment C
- GSM9626903 CB49847 treatment D
- GSM9626904 CB49847 uncultured
- GSM9626905 CB49916 treatment A
- GSM9626906 CB49916 treatment B
- GSM9626907 CB49916 treatment C
- GSM9626908 CB49916 treatment D
- GSM9626909 CB49916 uncultured
+ 5 more — browse all 45 samples with per-sample file links →
- GSE295260 CDK4/6 inhibition induces a senescence-associated secretory phenotype via delayed NF-κB activation 40 samples shares inhibition, senescence
- GSE328457 Pooled combinatorial screening identifies transcription factor sets that drive hematopoietic progenitor-like cell fate 39 samples shares hematopoietic, progenitor
- GSE323983 Senescence inhibition by rapamycin mitigates radiation-induced atherosclerotic characteristics in human coronary endothelial cells 23 samples shares inhibition, senescence
- GSE267423 In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles 11 samples shares hematopoietic, progenitor
- GSE287227 Transient SP140 inhibition unlocks hematopoietic stem cell fate from human pluripotent stem cells [scRNA-seq] 9 samples shares hematopoietic, inhibition
- GSE244257 Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6 mediated gene editing in hematopoietic stem cells 83 samples shares hematopoietic, senescence
- GSE267496 In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles [cell line panel] 11 samples shares hematopoietic, progenitor
- GSE285943 A reference model for circulating hematopoietic stem cells with applications to diagnostics 299 samples shares hematopoietic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.